AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
LONDON: AstraZeneca today announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect…